Skip to main content
Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report

Fig. 1

Calcemia, bone mineral density, and fracture events for a patient treated with denosumab for 9 years who experienced a rebound effect when treatment was stopped, with a combination of hypercalcemia related to hyperparathyroidism, multiple fractures, and rapid bone loss

Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947